MAPT and Alzheimer disease: However, recent data indicate that only about one-third of individuals with AD pathology follow the predicted sequence of the amyloid cascade, with substantial heterogeneity in the relationship between amyloid, tau, and clinical progression, and many patients exhibiting co-pathologies or resilience to amyloid burden [16,17].